These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32764408)
1. Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling. Mahmood I Antibodies (Basel); 2020 Aug; 9(3):. PubMed ID: 32764408 [TBL] [Abstract][Full Text] [Related]
2. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling. Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923 [TBL] [Abstract][Full Text] [Related]
3. Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human Clearance. Mahmood I Antibodies (Basel); 2021 Jan; 10(1):. PubMed ID: 33430196 [TBL] [Abstract][Full Text] [Related]
4. A Simple Method for the Prediction of Therapeutic Proteins (Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins) for First-in-Pediatric Dose Selection: Application of Salisbury Rule. Mahmood I Antibodies (Basel); 2022 Oct; 11(4):. PubMed ID: 36278619 [TBL] [Abstract][Full Text] [Related]
5. A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling for the Prediction of Drug Clearance From Neonates to Adolescents. Mahmood I; Tegenge MA J Clin Pharmacol; 2019 Feb; 59(2):189-197. PubMed ID: 30192373 [TBL] [Abstract][Full Text] [Related]
6. Initiation of Pediatric Clinical Trials for Coagulation Factors: Application of Pharmacokinetics and Allometry to First-in-Pediatric Dose Selection. Mahmood I J Clin Pharmacol; 2019 Jun; 59(6):829-834. PubMed ID: 30624769 [TBL] [Abstract][Full Text] [Related]
7. The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years. Edginton AN; Shah B; Sevestre M; Momper JD Clin Pharmacokinet; 2013 Aug; 52(8):693-703. PubMed ID: 23588537 [TBL] [Abstract][Full Text] [Related]
8. Model-Aided Adults-to-Children Pharmacokinetic Extrapolation and Empirical Body Size-Based Dosing Exploration for Therapeutic Monoclonal Antibodies-Is Allometry a Reasonable Choice? Xu Y; Langevin BA; Zhou H; Xu Z J Clin Pharmacol; 2020 Dec; 60(12):1573-1584. PubMed ID: 32578225 [TBL] [Abstract][Full Text] [Related]
9. Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling. Mahmood I; Ahmad T; Mansoor N; Sharib SM J Clin Pharmacol; 2017 Apr; 57(4):476-483. PubMed ID: 27704554 [TBL] [Abstract][Full Text] [Related]
10. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models. Mahmood I J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918 [TBL] [Abstract][Full Text] [Related]
11. Allometric extrapolation of factors VII, VIII and IX clearance in children from adults. Mahmood I J Thromb Haemost; 2012 Aug; 10(8):1609-13. PubMed ID: 22612736 [TBL] [Abstract][Full Text] [Related]
12. The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults. Wang C; Allegaert K; Peeters MY; Tibboel D; Danhof M; Knibbe CA Br J Clin Pharmacol; 2014 Jan; 77(1):149-59. PubMed ID: 23772816 [TBL] [Abstract][Full Text] [Related]
13. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach. Mahmood I Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778 [TBL] [Abstract][Full Text] [Related]
14. Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited. Wang W; Prueksaritanont T Biopharm Drug Dispos; 2010 May; 31(4):253-63. PubMed ID: 20437464 [TBL] [Abstract][Full Text] [Related]
15. Multistep Unified Models Using Prior Knowledge for the Prediction of Drug Clearance in Neonates and Infants. Tegenge MA; Mahmood I; Jiang Z; Forshee R J Clin Pharmacol; 2018 Jul; 58(7):877-884. PubMed ID: 29489016 [TBL] [Abstract][Full Text] [Related]
16. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults. Tegenge MA; Mahmood I Ther Drug Monit; 2018 Oct; 40(5):635-641. PubMed ID: 30086085 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods. Mahmood I; Cheng A; Brauer E; Humeniuk R Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):767-775. PubMed ID: 26547922 [TBL] [Abstract][Full Text] [Related]
19. Spreadsheet-Based Minimal Physiological Models for the Prediction of Clearance of Therapeutic Proteins in Pediatric Patients. Mahmood I; Tegenge MA J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S108-S116. PubMed ID: 34185903 [TBL] [Abstract][Full Text] [Related]
20. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach. Mahmood I Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]